S100A9, Mouse Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-S100A9, Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | S100A9, Mouse |
| Clone | MU14-2A5 |
| Host Species | Rat |
| Reactive Species | n/a |
| Isotype | IgG1 |
| Format | biotin conjugate |
| Size | 0.05 mg |
| Concentration | n/a |
| Applications | Frozen sections (F), Functional Studies (FS), Immuno Assay (IA), Immunofluorescence (IF), Paraffin sections (P), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The monoclonal antibody MU14-2A5 recognizes S100A9. The calcium-binding, migration inhibitory factor-related proteins, MRP-8 (S100A8) and MRP-14 (S100A9) belong to the S100 protein family. MRP14 is co-expressed with human MRP8, a homologue protein in myeloid cells, and plays an essential role in calcium dependent functions during inflammation. This role includes the activation of Mac-1, the beta2 integrin which is involved in neutrophil adhesion to endothelial cells. MRP14 is distinguished from other S100 member proteins by its long C-terminal region. The expression of MRP-8 (S100A8) and MRP-14 (S100A9) is largely confined to the cytosol of neutrophils and monocytes. The complex formation of these proteins is a calcium-dependent process. Th |
| Immunogen | Immunogen: Complete mouse S100A9 protein Conjugate: Biotin |
| Other Names | [Myeloid-related protein 14; MRP 14 or Calgranulin B], [S100A9; CAGB; CFAG; MRP14; MRP-14; p14] |
| Gene, Accession # | [S100A9], NCBI: CAG47020.1, UniProt: P06702 |
| Catalog # | MBS584685 |
| Price | $405 |
| Order / More Info | S100A9, Mouse Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies